Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
As of April 2025 Baxter has a market cap of S$20.29 Billion. This makes Baxter the world's 1185th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | S$20.29 B | 0.12% |
2024 | S$20.26 B | -21.76% |
2023 | S$25.90 B | -24.8% |
2022 | S$34.44 B | -40.72% |
2021 | S$58.10 B | 7.15% |
2020 | S$54.22 B | -4.97% |
2019 | S$57.06 B | 23.7% |
2018 | S$46.12 B | -2.07% |
2017 | S$47.10 B | 34.95% |
2016 | S$34.90 B | 18.11% |
2015 | S$29.55 B | -43.73% |
2014 | S$52.52 B | 9.77% |
2013 | S$47.85 B | 7.47% |
2012 | S$44.52 B | 23.23% |
2011 | S$36.13 B | -4.58% |
2010 | S$37.86 B | -23.52% |
2009 | S$49.50 B | 4.16% |
2008 | S$47.52 B | -10.32% |
2007 | S$52.99 B | 14.53% |
2006 | S$46.27 B | 18.12% |
2005 | S$39.17 B | 12.5% |
2004 | S$34.81 B | 9.31% |
2003 | S$31.85 B | 9.36% |
2002 | S$29.12 B | -51.01% |
2001 | S$59.45 B | 32.5% |
2000 | S$44.87 B | 47.85% |
1999 | S$30.35 B | -0.17% |
1998 | S$30.40 B | 27.67% |
1997 | S$23.81 B | 52.34% |
1996 | S$15.63 B |
On Apr 23rd, 2025 the market cap of Baxter was reported to be: